Dr. Janice May Wilson, MD

Dr. Wilson practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Wilson's NPI, 1457612749, was assigned on June 3, 2012. Dr. Wilson graduated from McGovern Medical School in 2015. Dr. Wilson holds Texas license BP20046284.

Dr. Wilson's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Wilson's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice. Dmand AI also links Dr. Wilson to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wilson practices. Vendor and product names are available with a free account.

Dermatology is Dr. Wilson's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Wilson is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Wilson's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists acne, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, joint cyst, psoriasis, rash and scalp rash among the conditions Dr. Wilson treats.

CMS data shows 1,892 Medicare services from Dr. Wilson across 12 procedure codes in 2024, for 624 Medicare patients. Medicare paid $48,333 for them.

CMS counts 624 Medicare patients who saw Dr. Wilson in 2024. The largest group is 65 to 74, with 313 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.14, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wilson's median patient age at 72, with 52% women.

In 2024, Dr. Wilson wrote 113 Medicare Part D claims for 50 patients. 67% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $57,345 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Wilson for performance year 2024, reported as part of a group. Dr. Wilson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 364 procedures of removal of skin lesions by Dr. Wilson, more than 84% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Wilson, published from 2011 to 2021. 2018 was the busiest year, with 4. The most frequent topics are Skin Neoplasms, Skin Diseases and Drug Eruptions. Dr. Wilson has published most often in J Am Acad Dermatol. Dr. Wilson's most frequent co-authors are Brent Christopher Kelly, MD, Julie Ann Croley, MD and Jeffrey E. Gershenwald, MD.

CMS Open Payments shows 7 general payments to Dr. Wilson from 7 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 75% of the total. Novartis Pharmaceuticals Corporation paid the most, $102.

Dr. Wilson graduated from McGovern Medical School in 2015.

Dr. Wilson is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.